Vectura asthma inhaler makes "positive" regulatory progress in Europe

From Reuters - October 4, 2017

(Reuters) - British drugmaker Vectura said its asthma inhaler Flutiform had made favorable regulatory progress in Europe, andit can now apply for approvals through its partner.

Vectura said its partner Mundipharma confirmed a successful outcome for the inhaler, when first assessed by the UK medicines and healthcare products regulatory agency -- which covers 18 countries across Europe.


Continue reading at Reuters »